Pierrette Seeldrayers

2.4k total citations · 1 hit paper
31 papers, 1.5k citations indexed

About

Pierrette Seeldrayers is a scholar working on Neurology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Pierrette Seeldrayers has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 10 papers in Pathology and Forensic Medicine and 8 papers in Rheumatology. Recurrent topics in Pierrette Seeldrayers's work include Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (5 papers) and Cell Adhesion Molecules Research (4 papers). Pierrette Seeldrayers is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (5 papers) and Cell Adhesion Molecules Research (4 papers). Pierrette Seeldrayers collaborates with scholars based in Belgium, United States and Netherlands. Pierrette Seeldrayers's co-authors include Per Soelberg Sørensen, Frederik Barkhof, Luca Durelli, Óscar Fernández, Massimo Filippi, Hans-Peter Hartung, Vittorio Martinelli, Giancarlo Comi, Gilles Edan and O. R. Hommes and has published in prestigious journals such as The Lancet, Neurology and Annals of Neurology.

In The Last Decade

Pierrette Seeldrayers

31 papers receiving 1.5k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

2001 757 citations Pierrette Seeldrayers et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pierrette Seeldrayers Belgium	16	1.0k	599	413	340	228	31	1.5k
C. Bash United States	17	890 0.9×	278 0.5×	337 0.8×	272 0.8×	267 1.2×	21	1.2k
Rainer Ehling Austria	21	1.1k 1.1×	792 1.3×	372 0.9×	293 0.9×	191 0.8×	52	1.8k
C. Milanese Italy	22	1.3k 1.3×	749 1.3×	344 0.8×	262 0.8×	291 1.3×	65	1.7k
Siegrid Strasser‐Fuchs Austria	17	820 0.8×	406 0.7×	285 0.7×	235 0.7×	146 0.6×	32	1.5k
R. Egg Austria	13	771 0.8×	479 0.8×	287 0.7×	380 1.1×	162 0.7×	14	1.4k
L. P. Weiner United States	9	1.7k 1.7×	834 1.4×	562 1.4×	496 1.5×	427 1.9×	11	2.1k
Neena Sarkar United States	7	1.5k 1.4×	595 1.0×	361 0.9×	1.1k 3.4×	470 2.1×	8	2.5k
B. Weinstock‐Guttman United States	19	1.3k 1.3×	423 0.7×	381 0.9×	327 1.0×	340 1.5×	27	1.7k
Channa Kolb United States	21	807 0.8×	301 0.5×	199 0.5×	175 0.5×	144 0.6×	50	1.2k
Luisa Caniatti Italy	19	662 0.6×	454 0.8×	335 0.8×	216 0.6×	109 0.5×	35	1.4k

Countries citing papers authored by Pierrette Seeldrayers

Since Specialization

Citations

This map shows the geographic impact of Pierrette Seeldrayers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierrette Seeldrayers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierrette Seeldrayers more than expected).

Fields of papers citing papers by Pierrette Seeldrayers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierrette Seeldrayers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierrette Seeldrayers. The network helps show where Pierrette Seeldrayers may publish in the future.

Co-authorship network of co-authors of Pierrette Seeldrayers

This figure shows the co-authorship network connecting the top 25 collaborators of Pierrette Seeldrayers. A scholar is included among the top collaborators of Pierrette Seeldrayers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierrette Seeldrayers. Pierrette Seeldrayers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Magyari, Melinda, Alice Koechlin, Antoine Duclos, et al.. (2024). Long‐Term Safety of Teriflunomide in Multiple Sclerosis Patients: Results of Prospective Comparative Studies in Three European Countries. Pharmacoepidemiology and Drug Safety. 33(7). e5866–e5866. 1 indexed citations

Decallonne, Brigitte, E Bartholomé, Valérie Delvaux, et al.. (2018). Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management. Acta Neurologica Belgica. 118(2). 153–159. 28 indexed citations

Costers, Lars, Jeroen Van Schependom, Ann Van Remoortel, et al.. (2017). Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation study. Multiple Sclerosis and Related Disorders. 18. 33–40. 34 indexed citations

Chatelle, Camille, C. Chaskis, Pierrette Seeldrayers, et al.. (2015). Is the Nociception Coma Scale-Revised a Useful Clinical Tool for Managing Pain in Patients With Disorders of Consciousness?. Clinical Journal of Pain. 32(4). 321–326. 38 indexed citations

Jongen, Peter Joseph, Dirk Lehnick, E. A. C. M. Sanders, et al.. (2010). Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study. Health and Quality of Life Outcomes. 8(1). 133–133. 41 indexed citations

Gonsette, R, Christian Sindic, Marie D’hooghe, et al.. (2010). Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon β in relapsing- remitting Multiple Sclerosis (ASIIMS) trial. Multiple Sclerosis Journal. 16(4). 455–462. 47 indexed citations

Abboud, Shérine, Leena E. Viiri, Dieter Lütjohann, et al.. (2008). Associations of apolipoprotein E gene with ischemic stroke and intracranial atherosclerosis. European Journal of Human Genetics. 16(8). 955–960. 34 indexed citations

Jacquy, J, et al.. (2006). A unique episode of REM sleep behavior disorder triggered during surgery for Parkinson's disease. Journal of the Neurological Sciences. 253(1-2). 73–76. 11 indexed citations

Dethy, Sophie, Jerzy Hildebrand, J Jacquy, et al.. (2003). Effects of the oral form of ondansetron on cerebellar dysfunction. Journal of Neurology. 250(6). 693–697. 22 indexed citations

10.

Hartung, Hans‐Peter, et al.. (1993). Soluble ICAM‐1 serum levels in multiple sclerosis and viral encephalitis. Neurology. 43(11). 2331–2331. 64 indexed citations

11.

Seeldrayers, Pierrette, Jutta Syha, Sean Morrissey, et al.. (1993). Magnetic resonance imaging investigation of blood-brain barrier damage in adoptive transfer experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 46(1-2). 199–206. 28 indexed citations

12.

Seeldrayers, Pierrette, Leonard A. Levin, & David K. Johnson. (1992). Astrocytes support mast cell viability in vitro. Journal of Neuroimmunology. 36(2-3). 239–243. 19 indexed citations

13.

Johnson, David, Dag H. Yasui, & Pierrette Seeldrayers. (1991). An Analysis of Mast Cell Frequency in the Rodent Nervous System: Numbers Vary between Different Strains and Can Be Reconstituted in Mast Cell-Deficient Mice. Journal of Neuropathology & Experimental Neurology. 50(3). 227–234. 53 indexed citations

14.

Seeldrayers, Pierrette, Dag H. Yasui, Howard L. Weiner, & David Johnson. (1989). Treatment of experimental allergic neuritis with nedocromil sodium. Journal of Neuroimmunology. 25(2-3). 221–226. 29 indexed citations

15.

Danielczyk, W, F. Forette, Jean‐Marc Orgogozo, et al.. (1988). CBM 36‐733 (2‐Methyl‐alpha‐ergokryptine) In primary degenerative dementia: Results of a european multicentre trial. International Journal of Geriatric Psychiatry. 3(2). 107–114. 1 indexed citations

16.

Johnson, David, Howard L. Weiner, & Pierrette Seeldrayers. (1988). Role of Mast Cells in Peripheral Nervous System Demyelination. Annals of the New York Academy of Sciences. 540(1). 727–728. 10 indexed citations

17.

Seeldrayers, Pierrette, et al.. (1987). Reversible capsulo-tegmental locked-in state as first manifestation of multiple sclerosis. Journal of the Neurological Sciences. 80(2-3). 153–161. 2 indexed citations

18.

Johnson, David, Howard L. Weiner, & Pierrette Seeldrayers. (1987). The role of mast cells in PNS demyelination. Journal of Neuroimmunology. 16(1). 84–84. 1 indexed citations

19.

Seeldrayers, Pierrette, Nicholas R Hoyle, & D. G. T. Thomas. (1984). Pre- and post-operative changes in serum immunoglobulin level in neurosurgical patients. Acta Neurochirurgica. 70(3-4). 269–274. 4 indexed citations

20.

Thomas, D. G. T., Nicholas R Hoyle, & Pierrette Seeldrayers. (1984). Myelin basic protein immunoreactivity in serum of neurosurgical patients.. Journal of Neurology Neurosurgery & Psychiatry. 47(2). 173–175. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact